Profile - To The Moon

堵神

Posts · 207Posts · 207
Following · 0Following · 0
Followers · 0Followers · 0

- 堵神堵神
  ·2023-03-15
  $AMC Entertainment(AMC)$ 🙄🙄🙄
  5.96K 1
  5
  Share
  Report
- 堵神堵神
  ·2021-09-08
  Nice ?
  Tesla sold 44,264 China-made vehicles in August -CPCA
  BEIJING, Sept 8 (Reuters) - U.S. electric vehicle maker Tesla Inc in August sold 44,264 China-made v
  Tesla sold 44,264 China-made vehicles in August -CPCA
  5.80K 2
  6
  Share
  Report
- 堵神堵神
  ·2021-09-08
  $Jaguar Animal Health(JAGX)$Hopeless ?
  4.59K Comment
  1
  Share
  Report
- 堵神堵神
  ·2021-09-06
  Likes
  Sorry, this post has been deleted
  4.56K Comment
  3
  Share
  Report
- 堵神堵神
  ·2021-08-31
  Like please ?
  Sorry, this post has been deleted
  4.25K Comment
  Like
  Share
  Report
- 堵神堵神
  ·2021-08-29
  Yeah
  Sorry, this post has been deleted
  5.97K 1
  2
  Share
  Report
- 堵神堵神
  ·2021-08-28
  Please like
  U.S. resumes supply of Lilly's COVID-19 antibody combo to some states
  Aug 27 (Reuters) - U.S. health officials on Friday decided to resume the supply of Eli Lilly's COVID
  U.S. resumes supply of Lilly's COVID-19 antibody combo to some states
  5.09K 2
  6
  Share
  Report
- 堵神堵神
  ·2021-08-27
  Wow ?
  Sorry, this post has been deleted
  5.91K 1
  Like
  Share
  Report
- 堵神堵神
  ·2021-08-27
  Latest
  Fed Chief Powell Speaks Later Today. Look for Taper Talk but No Clear Plans
  Federal Reserve Chairman Jerome Powell Anticipation has been running high for months ahead of the Fe
  Fed Chief Powell Speaks Later Today. Look for Taper Talk but No Clear Plans
  4.50K Comment
  Like
  Share
  Report
- 堵神堵神
  ·2021-08-12
  Nice ?
  Sorry, this post has been deleted
  5.69K 2
  2
  Share
  Report

Most Discussed

{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"3569643178216945","uuid":"3569643178216945","gmtCreate":1606549229245,"gmtModify":1622113528580,"name":"堵神","pinyin":"dsdushen","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/cacee5ba5c333e51bfcd4bed94dada85","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":19,"headSize":14,"tweetSize":207,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":1,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-4","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Tiger Star","description":"Join the tiger community for 2000 days","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.05.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"44212b71d0be4ec88898348dbe882e03-2","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Executive Tiger","description":"The transaction amount of the securities account reaches $300,000","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"80.52%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.51%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":9949780436,"gmtCreate":1678890994226,"gmtModify":1678890996944,"author":{"id":"3569643178216945","authorId":"3569643178216945","name":"堵神","avatar":"https://static.tigerbbs.com/cacee5ba5c333e51bfcd4bed94dada85","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3569643178216945","idStr":"3569643178216945"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/AMC\">$AMC Entertainment(AMC)$ &nbsp;</a>🙄🙄🙄","listText":"<a href=\"https://ttm.financial/S/AMC\">$AMC Entertainment(AMC)$ &nbsp;</a>🙄🙄🙄","text":"$AMC Entertainment(AMC)$ 🙄🙄🙄","images":[{"img":"https://community-static.tradeup.com/news/38cc32c4be108b792a4798c1cd6799af","width":"1080","height":"2182"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9949780436","isVote":1,"tweetType":1,"viewCount":5962,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":889085913,"gmtCreate":1631092007932,"gmtModify":1676530465325,"author":{"id":"3569643178216945","authorId":"3569643178216945","name":"堵神","avatar":"https://static.tigerbbs.com/cacee5ba5c333e51bfcd4bed94dada85","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3569643178216945","idStr":"3569643178216945"},"themes":[],"title":"","htmlText":"Nice ?","listText":"Nice ?","text":"Nice ?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/889085913","repostId":"2165858362","repostType":4,"repost":{"id":"2165858362","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1631091834,"share":"https://ttm.financial/m/news/2165858362?lang=en_US&edition=fundamental","pubTime":"2021-09-08 17:03","market":"us","language":"en","title":"Tesla sold 44,264 China-made vehicles in August -CPCA","url":"https://stock-news.laohu8.com/highlight/detail?id=2165858362","media":"Reuters","summary":"BEIJING, Sept 8 (Reuters) - U.S. electric vehicle maker Tesla Inc in August sold 44,264 China-made v","content":"<p>BEIJING, Sept 8 (Reuters) - U.S. electric vehicle maker Tesla Inc in August sold 44,264 China-made vehicles, including 31,379 for export, the China Passenger Car Association (CPCA) said on Wednesday.</p>\n<p>Local sales of China-made vehicles jumped to 12,885 cars last month from 8,621 cars in July. Tesla's sales in the first month of each quarter are usually lower than the following two months.</p>\n<p>The company, which makes Model 3 sedans and Model Y sport-utility vehicles in Shanghai, sold 32,968 China-made vehicles in July and 33,155 units in June.</p>\n<p>CPCA said passenger car sales in August in China totalled 1.5 million, down 14.7% from a year earlier.</p>\n<p>(Reporting by Yilei Sun and Brenda Goh; editing by David Evans)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla sold 44,264 China-made vehicles in August -CPCA</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla sold 44,264 China-made vehicles in August -CPCA\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-09-08 17:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BEIJING, Sept 8 (Reuters) - U.S. electric vehicle maker Tesla Inc in August sold 44,264 China-made vehicles, including 31,379 for export, the China Passenger Car Association (CPCA) said on Wednesday.</p>\n<p>Local sales of China-made vehicles jumped to 12,885 cars last month from 8,621 cars in July. Tesla's sales in the first month of each quarter are usually lower than the following two months.</p>\n<p>The company, which makes Model 3 sedans and Model Y sport-utility vehicles in Shanghai, sold 32,968 China-made vehicles in July and 33,155 units in June.</p>\n<p>CPCA said passenger car sales in August in China totalled 1.5 million, down 14.7% from a year earlier.</p>\n<p>(Reporting by Yilei Sun and Brenda Goh; editing by David Evans)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2165858362","content_text":"BEIJING, Sept 8 (Reuters) - U.S. electric vehicle maker Tesla Inc in August sold 44,264 China-made vehicles, including 31,379 for export, the China Passenger Car Association (CPCA) said on Wednesday.\nLocal sales of China-made vehicles jumped to 12,885 cars last month from 8,621 cars in July. Tesla's sales in the first month of each quarter are usually lower than the following two months.\nThe company, which makes Model 3 sedans and Model Y sport-utility vehicles in Shanghai, sold 32,968 China-made vehicles in July and 33,155 units in June.\nCPCA said passenger car sales in August in China totalled 1.5 million, down 14.7% from a year earlier.\n(Reporting by Yilei Sun and Brenda Goh; editing by David Evans)","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":5795,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":889082117,"gmtCreate":1631091964339,"gmtModify":1676530465294,"author":{"id":"3569643178216945","authorId":"3569643178216945","name":"堵神","avatar":"https://static.tigerbbs.com/cacee5ba5c333e51bfcd4bed94dada85","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3569643178216945","idStr":"3569643178216945"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/JAGX\">$Jaguar Animal Health(JAGX)$</a>Hopeless ?","listText":"<a href=\"https://laohu8.com/S/JAGX\">$Jaguar Animal Health(JAGX)$</a>Hopeless ?","text":"$Jaguar Animal Health(JAGX)$Hopeless ?","images":[{"img":"https://static.tigerbbs.com/6379214725f603cc43ae175915b9b747","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/889082117","isVote":1,"tweetType":1,"viewCount":4591,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":817152255,"gmtCreate":1630922974377,"gmtModify":1676530421372,"author":{"id":"3569643178216945","authorId":"3569643178216945","name":"堵神","avatar":"https://static.tigerbbs.com/cacee5ba5c333e51bfcd4bed94dada85","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3569643178216945","idStr":"3569643178216945"},"themes":[],"title":"","htmlText":"Likes","listText":"Likes","text":"Likes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/817152255","repostId":"1152804171","repostType":4,"isVote":1,"tweetType":1,"viewCount":4564,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":818364399,"gmtCreate":1630377127211,"gmtModify":1676530285290,"author":{"id":"3569643178216945","authorId":"3569643178216945","name":"堵神","avatar":"https://static.tigerbbs.com/cacee5ba5c333e51bfcd4bed94dada85","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3569643178216945","idStr":"3569643178216945"},"themes":[],"title":"","htmlText":"Like please ?","listText":"Like please ?","text":"Like please ?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/818364399","repostId":"1115065229","repostType":4,"isVote":1,"tweetType":1,"viewCount":4252,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":813618718,"gmtCreate":1630197317134,"gmtModify":1676530240120,"author":{"id":"3569643178216945","authorId":"3569643178216945","name":"堵神","avatar":"https://static.tigerbbs.com/cacee5ba5c333e51bfcd4bed94dada85","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3569643178216945","idStr":"3569643178216945"},"themes":[],"title":"","htmlText":"Yeah","listText":"Yeah","text":"Yeah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/813618718","repostId":"2162302126","repostType":4,"isVote":1,"tweetType":1,"viewCount":5970,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":819778411,"gmtCreate":1630111080233,"gmtModify":1676530226193,"author":{"id":"3569643178216945","authorId":"3569643178216945","name":"堵神","avatar":"https://static.tigerbbs.com/cacee5ba5c333e51bfcd4bed94dada85","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3569643178216945","idStr":"3569643178216945"},"themes":[],"title":"","htmlText":"Please like","listText":"Please like","text":"Please like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/819778411","repostId":"2162707824","repostType":4,"repost":{"id":"2162707824","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1630104635,"share":"https://ttm.financial/m/news/2162707824?lang=en_US&edition=fundamental","pubTime":"2021-08-28 06:50","market":"us","language":"en","title":"U.S. resumes supply of Lilly's COVID-19 antibody combo to some states","url":"https://stock-news.laohu8.com/highlight/detail?id=2162707824","media":"Reuters","summary":"Aug 27 (Reuters) - U.S. health officials on Friday decided to resume the supply of Eli Lilly's COVID","content":"<p>Aug 27 (Reuters) - U.S. health officials on Friday decided to resume the supply of Eli Lilly's COVID-19 antibody cocktail to states where variants resistant to it are low, saying the therapy could work against the fast-spreading Delta variant based on lab studies.</p>\n<p>The Department of Health and Human Services narrowed the scope of authorization for the dual-antibody therapy, bamlanivimab and etesevimab, to states including Colorado, Connecticut and Illinois, Indiana.</p>\n<p>With the Delta variant becoming the dominant strain, the prevalence of variants resistant to the therapy is steadily decreasing, the agency said</p>\n<p>Based on lab tests, the drugs administered together are expected to retain activity against the Delta variant, but not against Delta plus and variants first identified in Brazil, South Africa and Colombia, it said.</p>\n<p>The department had in June paused its distribution after the therapy failed to show effectiveness against the coronavirus variants that were first identified in Brazil and South Africa.</p>\n<p>The supply of standalone etesevimab to be paired with existing supply of bamlanivimab is also being resumed to some states.</p>\n<p>Regeneron's antibody therapy REGEN-COV, and GlaxoSmithKline Plc and partner Vir Biotechnology's</p>\n<p>sotrovimab may be used in all states, territories, and U.S. jurisdictions as they are likely to be effective against most variants including Delta, the agency said.</p>\n<p>Bamlanivimab and etesevimab, REGEN-COV and sotrovimab are authorized for use in people 12 years and above with mild-to-moderate infection and are at high risk for progression to severe COVID-19.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. resumes supply of Lilly's COVID-19 antibody combo to some states</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. resumes supply of Lilly's COVID-19 antibody combo to some states\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-28 06:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Aug 27 (Reuters) - U.S. health officials on Friday decided to resume the supply of Eli Lilly's COVID-19 antibody cocktail to states where variants resistant to it are low, saying the therapy could work against the fast-spreading Delta variant based on lab studies.</p>\n<p>The Department of Health and Human Services narrowed the scope of authorization for the dual-antibody therapy, bamlanivimab and etesevimab, to states including Colorado, Connecticut and Illinois, Indiana.</p>\n<p>With the Delta variant becoming the dominant strain, the prevalence of variants resistant to the therapy is steadily decreasing, the agency said</p>\n<p>Based on lab tests, the drugs administered together are expected to retain activity against the Delta variant, but not against Delta plus and variants first identified in Brazil, South Africa and Colombia, it said.</p>\n<p>The department had in June paused its distribution after the therapy failed to show effectiveness against the coronavirus variants that were first identified in Brazil and South Africa.</p>\n<p>The supply of standalone etesevimab to be paired with existing supply of bamlanivimab is also being resumed to some states.</p>\n<p>Regeneron's antibody therapy REGEN-COV, and GlaxoSmithKline Plc and partner Vir Biotechnology's</p>\n<p>sotrovimab may be used in all states, territories, and U.S. jurisdictions as they are likely to be effective against most variants including Delta, the agency said.</p>\n<p>Bamlanivimab and etesevimab, REGEN-COV and sotrovimab are authorized for use in people 12 years and above with mild-to-moderate infection and are at high risk for progression to severe COVID-19.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LLY":"礼来","VIR":"Vir Biotechnology, Inc.","REGN":"再生元制药公司"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2162707824","content_text":"Aug 27 (Reuters) - U.S. health officials on Friday decided to resume the supply of Eli Lilly's COVID-19 antibody cocktail to states where variants resistant to it are low, saying the therapy could work against the fast-spreading Delta variant based on lab studies.\nThe Department of Health and Human Services narrowed the scope of authorization for the dual-antibody therapy, bamlanivimab and etesevimab, to states including Colorado, Connecticut and Illinois, Indiana.\nWith the Delta variant becoming the dominant strain, the prevalence of variants resistant to the therapy is steadily decreasing, the agency said\nBased on lab tests, the drugs administered together are expected to retain activity against the Delta variant, but not against Delta plus and variants first identified in Brazil, South Africa and Colombia, it said.\nThe department had in June paused its distribution after the therapy failed to show effectiveness against the coronavirus variants that were first identified in Brazil and South Africa.\nThe supply of standalone etesevimab to be paired with existing supply of bamlanivimab is also being resumed to some states.\nRegeneron's antibody therapy REGEN-COV, and GlaxoSmithKline Plc and partner Vir Biotechnology's\nsotrovimab may be used in all states, territories, and U.S. jurisdictions as they are likely to be effective against most variants including Delta, the agency said.\nBamlanivimab and etesevimab, REGEN-COV and sotrovimab are authorized for use in people 12 years and above with mild-to-moderate infection and are at high risk for progression to severe COVID-19.","news_type":1,"symbols_score_info":{"VIR":0.9,"REGN":0.9,"LLY":0.9}},"isVote":1,"tweetType":1,"viewCount":5089,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":819821011,"gmtCreate":1630056148433,"gmtModify":1676530212384,"author":{"id":"3569643178216945","authorId":"3569643178216945","name":"堵神","avatar":"https://static.tigerbbs.com/cacee5ba5c333e51bfcd4bed94dada85","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3569643178216945","idStr":"3569643178216945"},"themes":[],"title":"","htmlText":"Wow ?","listText":"Wow ?","text":"Wow ?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/819821011","repostId":"1107360724","repostType":4,"isVote":1,"tweetType":1,"viewCount":5913,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":819823369,"gmtCreate":1630056101051,"gmtModify":1676530212367,"author":{"id":"3569643178216945","authorId":"3569643178216945","name":"堵神","avatar":"https://static.tigerbbs.com/cacee5ba5c333e51bfcd4bed94dada85","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3569643178216945","idStr":"3569643178216945"},"themes":[],"title":"","htmlText":"Latest","listText":"Latest","text":"Latest","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/819823369","repostId":"1130148125","repostType":4,"repost":{"id":"1130148125","kind":"news","pubTimestamp":1630054176,"share":"https://ttm.financial/m/news/1130148125?lang=en_US&edition=fundamental","pubTime":"2021-08-27 16:49","market":"us","language":"en","title":"Fed Chief Powell Speaks Later Today. Look for Taper Talk but No Clear Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=1130148125","media":"Barrons","summary":"Federal Reserve Chairman Jerome Powell\nAnticipation has been running high for months ahead of the Fe","content":"<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/466fdbcfcf4fa4351400283595508cb9\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Federal Reserve Chairman Jerome Powell</span></p>\n<p>Anticipation has been running high for months ahead of the Federal Reserve’s annual Jackson Hole symposium which, for a second straight year, isn’t actually happening in the Wyoming ski resort town. The day is finally here, but investors will likely be left unsatisfied.</p>\n<p>While investors are hungry for clarity over plans to taper the emergency bond-buying program launched in response to the pandemic, odds are that Chairman Jerome Powell won’t deliver it when he speaks during the remote conference at 10 a.m. Eastern time. This&nbsp;is in part because of the economic headwinds posed by resurgent Covid-19 cases and a reluctance to front-run the Fed’s policy-making committee, which next meets Sept. 21-22.</p>\n<p>The Fed’s own scrapped in-person plans highlight Covid’s threat to the economy at a time when economists, employers and Fed officials themselves have been counting on millions of workers returning to the labor market in September, thereby relieving the labor shortage that is at the center of the everything-shortage. And these Covid headwinds come as economic and corporate earnings growth is already peaking, strategists say, and geopolitical risks are rising.</p>\n<p>That’s not to say there aren’t plenty of reasons to believe Powell will hit lots of dovish notes.&nbsp;After all, the Delta variant and the economic threat it poses offers a convenient out for officials on the fence about starting to taper this year.</p>\n<p>But his task is fraught. He not only needs to sound sufficiently dovish to avoid upsetting markets anxious about the wind-down of the Fed’s $120 billion in monthly Treasury and mortgage-backed securities purchases, but he also needs to soft-pedal those headwinds or he risks spooking markets. At the same time, many investors are looking for Powell to acknowledge inflation that has been both hotter and persistent than the Fed has forecast.</p>\n<p>Add it all up and the Fed chief must try to balance competing forces. The easiest thing to do: say as little as possible. Yet even if Powell doesn’t deliver answers, one thing seems certain. A taper announcement before November is increasingly unlikely, and expectations for a delay to the start of monthly purchase reductions until 2022 are building.</p>\n<p>To that point, what Powell doesn’t say during his speech, and the Q&amp;A to follow it, may wind up more important than what he does say.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fed Chief Powell Speaks Later Today. Look for Taper Talk but No Clear Plans</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFed Chief Powell Speaks Later Today. Look for Taper Talk but No Clear Plans\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 16:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/fed-chief-powell-speaks-later-today-look-for-taper-talk-but-no-clear-plans-51630011365?mod=hp_LATEST><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Federal Reserve Chairman Jerome Powell\nAnticipation has been running high for months ahead of the Federal Reserve’s annual Jackson Hole symposium which, for a second straight year, isn’t actually ...</p>\n\n<a href=\"https://www.barrons.com/articles/fed-chief-powell-speaks-later-today-look-for-taper-talk-but-no-clear-plans-51630011365?mod=hp_LATEST\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"source_url":"https://www.barrons.com/articles/fed-chief-powell-speaks-later-today-look-for-taper-talk-but-no-clear-plans-51630011365?mod=hp_LATEST","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1130148125","content_text":"Federal Reserve Chairman Jerome Powell\nAnticipation has been running high for months ahead of the Federal Reserve’s annual Jackson Hole symposium which, for a second straight year, isn’t actually happening in the Wyoming ski resort town. The day is finally here, but investors will likely be left unsatisfied.\nWhile investors are hungry for clarity over plans to taper the emergency bond-buying program launched in response to the pandemic, odds are that Chairman Jerome Powell won’t deliver it when he speaks during the remote conference at 10 a.m. Eastern time. This is in part because of the economic headwinds posed by resurgent Covid-19 cases and a reluctance to front-run the Fed’s policy-making committee, which next meets Sept. 21-22.\nThe Fed’s own scrapped in-person plans highlight Covid’s threat to the economy at a time when economists, employers and Fed officials themselves have been counting on millions of workers returning to the labor market in September, thereby relieving the labor shortage that is at the center of the everything-shortage. And these Covid headwinds come as economic and corporate earnings growth is already peaking, strategists say, and geopolitical risks are rising.\nThat’s not to say there aren’t plenty of reasons to believe Powell will hit lots of dovish notes. After all, the Delta variant and the economic threat it poses offers a convenient out for officials on the fence about starting to taper this year.\nBut his task is fraught. He not only needs to sound sufficiently dovish to avoid upsetting markets anxious about the wind-down of the Fed’s $120 billion in monthly Treasury and mortgage-backed securities purchases, but he also needs to soft-pedal those headwinds or he risks spooking markets. At the same time, many investors are looking for Powell to acknowledge inflation that has been both hotter and persistent than the Fed has forecast.\nAdd it all up and the Fed chief must try to balance competing forces. The easiest thing to do: say as little as possible. Yet even if Powell doesn’t deliver answers, one thing seems certain. A taper announcement before November is increasingly unlikely, and expectations for a delay to the start of monthly purchase reductions until 2022 are building.\nTo that point, what Powell doesn’t say during his speech, and the Q&A to follow it, may wind up more important than what he does say.","news_type":1,"symbols_score_info":{".SPX":0.9,".IXIC":0.9,".DJI":0.9}},"isVote":1,"tweetType":1,"viewCount":4497,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":895410394,"gmtCreate":1628764293418,"gmtModify":1676529846565,"author":{"id":"3569643178216945","authorId":"3569643178216945","name":"堵神","avatar":"https://static.tigerbbs.com/cacee5ba5c333e51bfcd4bed94dada85","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3569643178216945","idStr":"3569643178216945"},"themes":[],"title":"","htmlText":"Nice ?","listText":"Nice ?","text":"Nice ?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/895410394","repostId":"2158125503","repostType":4,"isVote":1,"tweetType":1,"viewCount":5691,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":true}